| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/15/2000 | CN1247229A Paddy rice group of preventing rice blast |
| 03/14/2000 | US6038627 SRAM bus architecture and interconnect to an FPGA |
| 03/14/2000 | US6037523 Nucleotide sequences which are regulatory sequences which control preferential expression of exogenous genes in plants; for tissue preferential expression of genes |
| 03/14/2000 | US6037521 Transgenic mouse expressing an β-Amyloid transgene |
| 03/14/2000 | US6037462 Nucleic acids sequences with somatic adjustments in the multiple tumor suppressor gene in human cancers; for diagnosis and treatment of human cancer; anticarciongenic agents; antitumor agents |
| 03/14/2000 | US6037461 FADD-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same |
| 03/14/2000 | US6037457 Method for recombinant fibrinogen production |
| 03/14/2000 | US6037456 Process for isolating and purifying viruses, soluble proteins and peptides from plant sources |
| 03/14/2000 | US6037455 Propoxyphene derivatives and protein and polypeptide propoxyphene derivative conjugates and labels |
| 03/14/2000 | US6037450 Genetically engineered binding polypeptide where carboxy terminal cysteine is replaced or is not palmitoylated; for the diagnosis and treatment of inflammation and autoimmune diseases; antiinflammatory agents |
| 03/14/2000 | US6037449 Polypeptide associated with bone and dentin tissues; for osteoporosis and bone cancer diagnosis; antiinflammatory agents |
| 03/14/2000 | US6037448 Chimeric viral protein with human lymphocyte determinant; for vaccine development against infection |
| 03/14/2000 | US6037446 Gestational agents for controlling cell proliferation |
| 03/14/2000 | US6037329 Compositions containing nucleic acids and ligands for therapeutic treatment |
| 03/14/2000 | US6037324 Madcam-1 (mucosal addressin cell adhesion molecule-1); useful in the treatment of inflammatory bowel diseases and other diseases involving leukocyte infiltration of the gastrointestinal tract or other mucosal tissues |
| 03/14/2000 | US6037323 Peptides and peptide analogues that mimic the structural and pharmacological properties of human apoa-i; treating disorders associated with dyslipoproteinemia, including hypercholesterolemia, cardiovascular disease, atherosclerosis, |
| 03/14/2000 | US6037321 Fusion proteins comprising vasoactive intestinal peptide or PACAP |
| 03/14/2000 | US6037320 Neurotrophic factor (NT-4) |
| 03/14/2000 | US6037173 Nucleic acid molecule that codes a thyroid receptor binding protein; for diagnosis and treatment of diseases associated with defects in the function of thyroid binding protein; for detection of mudulators of protein function |
| 03/14/2000 | US6037165 Methods for the preparation of human immunodeficiency virus type 2 (HIV-2) and antigens encoped thereby |
| 03/14/2000 | US6037163 Human microfibril-associated glycoprotein 4 splice variant |
| 03/14/2000 | US6037150 Insect sequences for improving the efficiency of secretion of non-secreted proteins in eukaryotic cells |
| 03/14/2000 | US6037149 Nucleotide sequence coding human interleukin-9; for the diagnosis of sensitivity to allergy and asthma |
| 03/14/2000 | US6037148 Nucleotide sequence coding mammalian transcription factor polypeptide; for the treatment of diseases associated with loss of tissue stability |
| 03/14/2000 | US6037147 Nucleotide sequence coding electron transfer protein |
| 03/14/2000 | US6037146 CDNA clone HE8CH90 that encodes a novel 7-transmembrane receptor |
| 03/14/2000 | US6037144 Method of preparing a biological material for use in ophthalmology |
| 03/14/2000 | US6037143 Genetically engineered protein for the treament of diabetes, osteoporosis and endometriosis |
| 03/14/2000 | US6037135 Methods for making HLA binding peptides and their uses |
| 03/14/2000 | US6037134 Methods that detect compounds that disrupt receptor tyrosine kinase/GRB-7 complexes |
| 03/14/2000 | US6037133 IκBEGFP constructs, cell lines and methods of use |
| 03/14/2000 | US6037132 Method for detecting HTRAN polynucleotides |
| 03/14/2000 | US6037131 Screening candidate compound for ability to alter transcription from gene promoter; providing recombinant cell, contacting cell with candidate compound, detecting expression pattern of reporter gene in the presence candidate compound |
| 03/14/2000 | US6037125 Disruption of the mammalian RAD51 protein and disruption of proteins that associate with mammalian RAD51 for hindering cell proliferation and/or viability of proliferating cells |
| 03/14/2000 | US6037121 DNA sequence encoding a tumor suppressor gene |
| 03/14/2000 | US6037117 Methods using the Staphylococcus aureus glycyl tRNA synthetase crystalline structure |
| 03/14/2000 | US6036961 Immunogenic antigens of giardia cultures in bile |
| 03/14/2000 | US6036960 Filamentous hemagglutinin of B. pertussis |
| 03/14/2000 | US6036959 HCMV/HSV fusion glycoproteins |
| 03/14/2000 | US6036958 Tsetse thrombin inhibitor |
| 03/14/2000 | US6036957 Immunology suppression with cd4 and t-cells reactive with mylin protein |
| 03/14/2000 | US6036955 Antitumor agents |
| 03/14/2000 | US6036953 Dna encoding with escherichia coli and fusion polypeptides |
| 03/14/2000 | CA2281935A1 Streptomyces avermitilis regulatory genes for increased avermectin production |
| 03/14/2000 | CA2163229C Method for examining neurovirulence of polio virus |
| 03/14/2000 | CA2163081C Thermoresistant alpha-1-antitrypsin mutein |
| 03/14/2000 | CA2143335C Isolated nonapeptide derived from mage-3 gene and presented by hla-a1, and uses thereof |
| 03/14/2000 | CA2132424C Antisense oligonucleotide inhibition of papillomavirus |
| 03/14/2000 | CA2123593C Method of treating tnf-dependent inflammation using tumor necrosis factor antagonists |
| 03/14/2000 | CA2098483C Safe adeno-associated virus 2 vector for gene therapy |
| 03/14/2000 | CA2071205C Cell surface antigen associated with cellular apoptosis |
| 03/14/2000 | CA2010778C Bioactive agents, compositions and materials comprising said bioactive agents |
| 03/14/2000 | CA2010177C Purified mite allergen |
| 03/14/2000 | CA2008817C M-csf monoclonal antibodies that recognize a neutralizing conformational epitope |
| 03/14/2000 | CA2006969C Polypeptide having human monocyte chemotactic factor activity and a dna encoding said polypeptide |
| 03/14/2000 | CA1340926C Human rhinovirus peptides |
| 03/14/2000 | CA1340924C Structural phosphoprotein (pp 150) of human cytomegalovirus, and the preparation thereof |
| 03/09/2000 | WO2000013019A1 Receptor for underivatized, aqueous soluble beta-(1,3)-glucan |
| 03/09/2000 | WO2000012762A1 A novel protein related to melanoma-inhibiting protein and uses thereof |
| 03/09/2000 | WO2000012754A1 Method for identifying substances for the treatment of c-jun-mediated disorders |
| 03/09/2000 | WO2000012740A2 ADENOVIRUSES DELETED IN THE IVa2, 100K AND/OR PRETERMINAL PROTEIN SEQUENCES |
| 03/09/2000 | WO2000012738A1 Targeted adenovirus vectors for delivery of heterologous genes |
| 03/09/2000 | WO2000012737A1 Guanylate binding protein (gbp-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation |
| 03/09/2000 | WO2000012736A2 A new method of identifying non-host plant disease resistance genes |
| 03/09/2000 | WO2000012735A2 Transgene assay using stable agrobacterium rhizogenes transformation |
| 03/09/2000 | WO2000012733A1 Seed-preferred promoters from end genes |
| 03/09/2000 | WO2000012732A2 Organelle targeting sequences |
| 03/09/2000 | WO2000012728A1 Expression of clostridial toxins and proteins |
| 03/09/2000 | WO2000012727A1 Fusion proteins, dna molecules, vectors, and host cells useful for measuring protease activity |
| 03/09/2000 | WO2000012716A2 MAIZE Ku70 ORTHOLOGUE AND USES THEREOF |
| 03/09/2000 | WO2000012715A1 Modification of plant fibres |
| 03/09/2000 | WO2000012713A1 Plant promoter sequence and uses therefor |
| 03/09/2000 | WO2000012712A1 Novel nerve differentiation factor |
| 03/09/2000 | WO2000012711A2 Human membrane channel proteins |
| 03/09/2000 | WO2000012710A1 Nucleic acids encoding ataxin-2 binding proteins, products related thereto and methods of using same |
| 03/09/2000 | WO2000012709A2 Phelix: a testis-specific protein expressed in cancer |
| 03/09/2000 | WO2000012708A2 Further pro polypeptides and sequences thereof |
| 03/09/2000 | WO2000012707A1 14926 receptor, a novel g-protein coupled receptor |
| 03/09/2000 | WO2000012706A1 Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor |
| 03/09/2000 | WO2000012705A2 Methods for improving the function of heterologous g protein-coupled receptors |
| 03/09/2000 | WO2000012704A2 Enhanced functional expression of g protein-coupled receptors |
| 03/09/2000 | WO2000012703A2 Protein transport-associated molecules |
| 03/09/2000 | WO2000012702A2 Human genes differentially expressed in colorectal cancer |
| 03/09/2000 | WO2000012701A1 Novel tumor antigen protein sart-3 and tumor antigen peptide thereof |
| 03/09/2000 | WO2000012700A1 GENE ENCODING CDw108 |
| 03/09/2000 | WO2000012699A1 A transcription factor tfiid subunit, tafii105, polypeptides, dna encoding therefor and pharmaceutical compositions |
| 03/09/2000 | WO2000012698A1 Human deltex-like gene zdx |
| 03/09/2000 | WO2000012697A1 CLONING AND EXPRESSION OF BOVINE ESTROGEN RECEPTOR-$g(b) |
| 03/09/2000 | WO2000012696A1 Cell specific promoters of uncoupling protein 3 |
| 03/09/2000 | WO2000012695A1 Novel therapeutic molecules and uses therefor |
| 03/09/2000 | WO2000012694A1 Chromosome 1-linked prostate cancer susceptibility gene and multisite tumor suppressor |
| 03/09/2000 | WO2000012693A1 Dna transfer technology for shuttling large inserts into mammalian cells |
| 03/09/2000 | WO2000012692A1 Dna encoding a gababr2 polypeptide and uses thereof |
| 03/09/2000 | WO2000012690A2 Laminin 5 for treatment of bone defects |
| 03/09/2000 | WO2000012689A1 Polypeptides and polynucleotides from coagulase-negative staphylococci |
| 03/09/2000 | WO2000012688A1 Ehrlichia canis 120-kda immunodominant antigenic protein and gene |
| 03/09/2000 | WO2000012685A2 Genes associated with neurotransmitter processing |
| 03/09/2000 | WO2000012681A1 Compositions and methods for producing high-level seed-specific gene expression in corn |
| 03/09/2000 | WO2000012680A1 Transformation, selection, and screening of sequence-shuffled polynucleotides for development and optimization of plant phenotypes |
| 03/09/2000 | WO2000012678A2 Staphylococcus aureus genes and polypeptides |